Seegene Completes $16.6M IPO on Korea's KOSDAQ
September 16, 2010
Seegene Completes $16.6M IPO on Korea's KOSDAQ
The company will use the cash infusion to expand its international market presence, with an emphasis on the US and Japan, where it is seeking regulatory approval for a number of multiplex PCR-based diagnostic tests.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Seegene, Selventa Partner on MDx Development for 'Underserved Markets'
April 23, 2013 / GenomeWeb Daily News - Seegene Licenses Multiplex Assay Technologies to BioMerieux for Food Safety Testing
April 15, 2013 / GenomeWeb Daily News - Seegene, DuPont Ink MDx Tech Licensing Deal
December 10, 2012 / GenomeWeb Daily News - At NGS-Heavy AMP Meeting, Clinical Researchers Still Get Behind PCR for Infectious Disease Dx
November 1, 2012 / PCR Insider - Seegene to Make Partnership Push with New Multiplex Real-Time PCR Tech
July 20, 2012 / GenomeWeb Daily News